Cargando…

Biocompatibility and Antibiofilm Properties of Calcium Silicate-Based Cements: An In Vitro Evaluation and Report of Two Clinical Cases

SIMPLE SUMMARY: Calcium silicate-based cements are successfully applied in the different fields of endodontics and vital pulp therapy. To better assess the properties of these bioactive materials, the present in vitro and in vivo study aimed to compare the biocompatibility and antibiofilm properties...

Descripción completa

Detalles Bibliográficos
Autores principales: Bossù, Maurizio, Mancini, Patrizia, Bruni, Erika, Uccelletti, Daniela, Preziosi, Adele, Rulli, Marco, Relucenti, Michela, Donfrancesco, Orlando, Iaculli, Flavia, Di Giorgio, Gianni, Matassa, Roberto, Salucci, Alessandro, Polimeni, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226987/
https://www.ncbi.nlm.nih.gov/pubmed/34073519
http://dx.doi.org/10.3390/biology10060470
_version_ 1783712418056110080
author Bossù, Maurizio
Mancini, Patrizia
Bruni, Erika
Uccelletti, Daniela
Preziosi, Adele
Rulli, Marco
Relucenti, Michela
Donfrancesco, Orlando
Iaculli, Flavia
Di Giorgio, Gianni
Matassa, Roberto
Salucci, Alessandro
Polimeni, Antonella
author_facet Bossù, Maurizio
Mancini, Patrizia
Bruni, Erika
Uccelletti, Daniela
Preziosi, Adele
Rulli, Marco
Relucenti, Michela
Donfrancesco, Orlando
Iaculli, Flavia
Di Giorgio, Gianni
Matassa, Roberto
Salucci, Alessandro
Polimeni, Antonella
author_sort Bossù, Maurizio
collection PubMed
description SIMPLE SUMMARY: Calcium silicate-based cements are successfully applied in the different fields of endodontics and vital pulp therapy. To better assess the properties of these bioactive materials, the present in vitro and in vivo study aimed to compare the biocompatibility and antibiofilm properties of ProRoot MTA and Biodentine. Human osteogenic sarcoma (Saos-2) cells were cultured in the presence of both materials and evaluated. Moreover, the bioactive cements were in vivo applied to perform vital pulp therapy on immature permanent teeth affected by reversible pulpitis. Saos-2 cells’ viability was slightly greater in the presence of ProRootMTA than Biodentine and cells would grow in a better way on ProRootMTA disks than on Biodentine ones. Moreover, ProRootMTA showed a powerful antibiofilm effect towards Streptococcus mutans. The in vitro results were clinically supported by a 100% success rate after 2 years of follow-up. ABSTRACT: Calcium silicate-based cements have reached excellent levels of performance in endodontics, providing predictable and successful results. To better assess the properties of these bioactive materials, the present study aimed to compare the biocompatibility and antibiofilm properties of ProRoot MTA and Biodentine. Human osteogenic sarcoma (Saos-2) cells were cultured on ProRoot MTA and Biodentine samples or in the presence of both cement extracts. Cell viability assay, measurement of reactive oxygen species (ROS), immunofluorescence analysis, as well as morphological evaluations were conducted. Moreover, Streptococcus mutans was used to assess the biofilm forming ability on ProRoot MTA and Biodentine disks. Finally, both cements were applied in vivo to treat immature permanent teeth affected by reversible pulpitis. Results: Cell viability assay demonstrated that Saos-2 cells had a dose- and time-dependent cytotoxicity to both analyzed cements, although cells exposed to ProRoot MTA showed a better cell vitality than those exposed to Biodentine (p < 0.001). Both cements demonstrated ROS production while this was greater in the case of Biodentine than ProRoot MTA (p < 0.001). Immunofluorescence images of the cytoskeleton and focal adhesions showed no differences in Saos-2 cells grown in the presence of ProRoot MTA eluate; whereas in the Biodentine groups, cells showed a morphology and focal adhesions more similar to that of the control sample, as the eluate concentration decreased. Morphological analysis revealed that Saos-2 cells were more flattened and exhibited better spreading when attached to ProRoot MTA disks than to Biodentine ones. The antibiofilm properties showed a time-dependent powerful inhibition of S. mutans superficial colonization and an antibiofilm effect of both cements. Clinically, complete root formation of the treated elements was achieved using the two studied cements, showing stable results over time. ProRoot MTA and Biodentine was demonstrated to be biocompatible and to possess antibiofilm properties. Their clinical application in vital pulp therapy provided successful outcomes after 2 years of follow-up.
format Online
Article
Text
id pubmed-8226987
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82269872021-06-26 Biocompatibility and Antibiofilm Properties of Calcium Silicate-Based Cements: An In Vitro Evaluation and Report of Two Clinical Cases Bossù, Maurizio Mancini, Patrizia Bruni, Erika Uccelletti, Daniela Preziosi, Adele Rulli, Marco Relucenti, Michela Donfrancesco, Orlando Iaculli, Flavia Di Giorgio, Gianni Matassa, Roberto Salucci, Alessandro Polimeni, Antonella Biology (Basel) Article SIMPLE SUMMARY: Calcium silicate-based cements are successfully applied in the different fields of endodontics and vital pulp therapy. To better assess the properties of these bioactive materials, the present in vitro and in vivo study aimed to compare the biocompatibility and antibiofilm properties of ProRoot MTA and Biodentine. Human osteogenic sarcoma (Saos-2) cells were cultured in the presence of both materials and evaluated. Moreover, the bioactive cements were in vivo applied to perform vital pulp therapy on immature permanent teeth affected by reversible pulpitis. Saos-2 cells’ viability was slightly greater in the presence of ProRootMTA than Biodentine and cells would grow in a better way on ProRootMTA disks than on Biodentine ones. Moreover, ProRootMTA showed a powerful antibiofilm effect towards Streptococcus mutans. The in vitro results were clinically supported by a 100% success rate after 2 years of follow-up. ABSTRACT: Calcium silicate-based cements have reached excellent levels of performance in endodontics, providing predictable and successful results. To better assess the properties of these bioactive materials, the present study aimed to compare the biocompatibility and antibiofilm properties of ProRoot MTA and Biodentine. Human osteogenic sarcoma (Saos-2) cells were cultured on ProRoot MTA and Biodentine samples or in the presence of both cement extracts. Cell viability assay, measurement of reactive oxygen species (ROS), immunofluorescence analysis, as well as morphological evaluations were conducted. Moreover, Streptococcus mutans was used to assess the biofilm forming ability on ProRoot MTA and Biodentine disks. Finally, both cements were applied in vivo to treat immature permanent teeth affected by reversible pulpitis. Results: Cell viability assay demonstrated that Saos-2 cells had a dose- and time-dependent cytotoxicity to both analyzed cements, although cells exposed to ProRoot MTA showed a better cell vitality than those exposed to Biodentine (p < 0.001). Both cements demonstrated ROS production while this was greater in the case of Biodentine than ProRoot MTA (p < 0.001). Immunofluorescence images of the cytoskeleton and focal adhesions showed no differences in Saos-2 cells grown in the presence of ProRoot MTA eluate; whereas in the Biodentine groups, cells showed a morphology and focal adhesions more similar to that of the control sample, as the eluate concentration decreased. Morphological analysis revealed that Saos-2 cells were more flattened and exhibited better spreading when attached to ProRoot MTA disks than to Biodentine ones. The antibiofilm properties showed a time-dependent powerful inhibition of S. mutans superficial colonization and an antibiofilm effect of both cements. Clinically, complete root formation of the treated elements was achieved using the two studied cements, showing stable results over time. ProRoot MTA and Biodentine was demonstrated to be biocompatible and to possess antibiofilm properties. Their clinical application in vital pulp therapy provided successful outcomes after 2 years of follow-up. MDPI 2021-05-26 /pmc/articles/PMC8226987/ /pubmed/34073519 http://dx.doi.org/10.3390/biology10060470 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bossù, Maurizio
Mancini, Patrizia
Bruni, Erika
Uccelletti, Daniela
Preziosi, Adele
Rulli, Marco
Relucenti, Michela
Donfrancesco, Orlando
Iaculli, Flavia
Di Giorgio, Gianni
Matassa, Roberto
Salucci, Alessandro
Polimeni, Antonella
Biocompatibility and Antibiofilm Properties of Calcium Silicate-Based Cements: An In Vitro Evaluation and Report of Two Clinical Cases
title Biocompatibility and Antibiofilm Properties of Calcium Silicate-Based Cements: An In Vitro Evaluation and Report of Two Clinical Cases
title_full Biocompatibility and Antibiofilm Properties of Calcium Silicate-Based Cements: An In Vitro Evaluation and Report of Two Clinical Cases
title_fullStr Biocompatibility and Antibiofilm Properties of Calcium Silicate-Based Cements: An In Vitro Evaluation and Report of Two Clinical Cases
title_full_unstemmed Biocompatibility and Antibiofilm Properties of Calcium Silicate-Based Cements: An In Vitro Evaluation and Report of Two Clinical Cases
title_short Biocompatibility and Antibiofilm Properties of Calcium Silicate-Based Cements: An In Vitro Evaluation and Report of Two Clinical Cases
title_sort biocompatibility and antibiofilm properties of calcium silicate-based cements: an in vitro evaluation and report of two clinical cases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226987/
https://www.ncbi.nlm.nih.gov/pubmed/34073519
http://dx.doi.org/10.3390/biology10060470
work_keys_str_mv AT bossumaurizio biocompatibilityandantibiofilmpropertiesofcalciumsilicatebasedcementsaninvitroevaluationandreportoftwoclinicalcases
AT mancinipatrizia biocompatibilityandantibiofilmpropertiesofcalciumsilicatebasedcementsaninvitroevaluationandreportoftwoclinicalcases
AT brunierika biocompatibilityandantibiofilmpropertiesofcalciumsilicatebasedcementsaninvitroevaluationandreportoftwoclinicalcases
AT uccellettidaniela biocompatibilityandantibiofilmpropertiesofcalciumsilicatebasedcementsaninvitroevaluationandreportoftwoclinicalcases
AT preziosiadele biocompatibilityandantibiofilmpropertiesofcalciumsilicatebasedcementsaninvitroevaluationandreportoftwoclinicalcases
AT rullimarco biocompatibilityandantibiofilmpropertiesofcalciumsilicatebasedcementsaninvitroevaluationandreportoftwoclinicalcases
AT relucentimichela biocompatibilityandantibiofilmpropertiesofcalciumsilicatebasedcementsaninvitroevaluationandreportoftwoclinicalcases
AT donfrancescoorlando biocompatibilityandantibiofilmpropertiesofcalciumsilicatebasedcementsaninvitroevaluationandreportoftwoclinicalcases
AT iaculliflavia biocompatibilityandantibiofilmpropertiesofcalciumsilicatebasedcementsaninvitroevaluationandreportoftwoclinicalcases
AT digiorgiogianni biocompatibilityandantibiofilmpropertiesofcalciumsilicatebasedcementsaninvitroevaluationandreportoftwoclinicalcases
AT matassaroberto biocompatibilityandantibiofilmpropertiesofcalciumsilicatebasedcementsaninvitroevaluationandreportoftwoclinicalcases
AT saluccialessandro biocompatibilityandantibiofilmpropertiesofcalciumsilicatebasedcementsaninvitroevaluationandreportoftwoclinicalcases
AT polimeniantonella biocompatibilityandantibiofilmpropertiesofcalciumsilicatebasedcementsaninvitroevaluationandreportoftwoclinicalcases